| Literature DB >> 35914128 |
Ning Deng1, Yun-Yun Wu2,3, Yanan Feng1, Wen-Chieh Hsieh3, Jen-Shin Song4, Yu-Shiuan Lin3, Ya-Hsien Tseng3, Wan-Jhu Liao3, Yi-Fan Chu5, Yu-Cheng Liu6, En-Cheng Chang3, Chia-Rung Liu3, Sheh-Yi Sheu5, Ming-Tsan Su7, Hung-Chih Kuo8, Stanley N Cohen1, Tzu-Hao Cheng2,3,9.
Abstract
Earlier work has shown that siRNA-mediated reduction of the SUPT4H or SUPT5H proteins, which interact to form the DSIF complex and facilitate transcript elongation by RNA polymerase II (RNAPII), can decrease expression of mutant gene alleles containing nucleotide repeat expansions differentially. Using luminescence and fluorescence assays, we identified chemical compounds that interfere with the SUPT4H-SUPT5H interaction and then investigated their effects on synthesis of mRNA and protein encoded by mutant alleles containing repeat expansions in the huntingtin gene (HTT), which causes the inherited neurodegenerative disorder, Huntington's Disease (HD). Here we report that such chemical interference can differentially affect expression of HTT mutant alleles, and that a prototypical chemical, 6-azauridine (6-AZA), that targets the SUPT4H-SUPT5H interaction can modify the biological response to mutant HTT gene expression. Selective and dose-dependent effects of 6-AZA on expression of HTT alleles containing nucleotide repeat expansions were seen in multiple types of cells cultured in vitro, and in a Drosophila melanogaster animal model for HD. Lowering of mutant HD protein and mitigation of the Drosophila "rough eye" phenotype associated with degeneration of photoreceptor neurons in vivo were observed. Our findings indicate that chemical interference with DSIF complex formation can decrease biochemical and phenotypic effects of nucleotide repeat expansions.Entities:
Keywords: DSIF; Huntington’s disease; SUPT4H; Spt4; nucleotide repeats
Mesh:
Substances:
Year: 2022 PMID: 35914128 PMCID: PMC9371670 DOI: 10.1073/pnas.2204779119
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 12.779